Nicotine Transdermal System Patch
Product Images NDC 3215-1201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicotine Transdermal System (NDC 3215-1201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aveva Drug Delivery Systems Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

21 mg Carton (Image001)

This is information for a Nicotine Transdermal System Patch, which delivers 21 mg of nicotine over 24 hours. It is a stop-smoking aid with 7 patches in Step 3 of the program. The package includes a self-help guide for assistance in quitting smoking.*

FDA Label Image

14 mg Carton (Image02)

This is a drug fact description for a Nicotine Transdermal System Patch, which delivers 14 mg of nicotine over 24 hours. It is a stop smoking aid program that includes a self-help guide. The package contains 7 patches.*

FDA Label Image

7 mg Carton (Imgae003)

This text appears to be describing a nicotine transdermal system patch for quitting smoking. The patch delivers 7 mg of nicotine over a 24-hour period and is part of a stop smoking aid program that includes a behavior support program. The package contains 7 patches to be used after completing step 2 of the program. The text also mentions information about the product, usage instructions, and an expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.